Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Sequenom, a developer of genetic analysis products, has terminated its exchange offer to acquire all of the outstanding shares of common stock of Exact Sciences, an applied genomics company, without accepting for exchange or exchanging any shares of Exact Sciences common stock.
Subscribe to our email newsletter
Sequenom has previously announced that it would terminate the exchange offer if Exact Sciences entered into any out-licensing agreement, collaboration or financial restructuring. Sequenom continues to be committed to building its oncology diagnostic franchise.